Biological Therapies of Severe Asthma and Their Possible Effects on Airway Remodeling
Asthma is a chronic and heterogenic respiratory tract disorder with a high global prevalence. The underlying chronic inflammatory process and airway remodeling (AR) contribute to the symptomatology of the disease. The most severely ill asthma patients may now be treated using a variety of monoclonal...
Main Authors: | Grzegorz Kardas, Piotr Kuna, Michał Panek |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01134/full |
Similar Items
-
Role of Platelet-Derived Growth Factor (PDGF) in Asthma as an Immunoregulatory Factor Mediating Airway Remodeling and Possible Pharmacological Target
by: Grzegorz Kardas, et al.
Published: (2020-02-01) -
The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review
by: Andrea Matucci, et al.
Published: (2018-08-01) -
Airway Remodeling in Asthma
by: Yuki Sumi, et al.
Published: (2007-01-01) -
Airway remodeling in asthma
by: Roni Naning, et al.
Published: (2001-06-01) -
Precision Medicine for Paediatric Severe Asthma: Current Status and Future Direction
by: Ramphul M, et al.
Published: (2021-05-01)